Abacus Medicine Pharmaceuticals ApS: Financial statements 2018
CVR: 39192063
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -61,772 and a net result of DKK 860,434. Equity amounted to DKK 15,336,184. The solvency ratio was 71.2%.
- Gross Profit
- -61,772 kr.
- Profit/Loss
- 860,434 kr.
- Equity
- 15,336,184 kr.
- Total Assets
- 21,533,789 kr.
Keep an eye on Abacus Medicine Pharmaceuticals ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity amounted to DKK 14,264,000.
